First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria)
Brand Names: First Degree
Methodology & AI Transparency ⓘ
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Formulated with active pharmaceutical ingredient Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria and registered by Welmedix LLC, First Degree operates as a over-the-counter branded over-the-counter clinical monograph therapy (RxNorm RXN-B24330110; NDC 24330-110).
- 2 Real-world patient consensus: Commercial First Degree monograph (1 [hp_Q]/.1g / 1 [hp_Q]/.1g Tincture) cross-indexed with generic Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria for therapeutic equivalence review.
- 3 Typical cash cost range: 30-day cash pricing ranges from $127.30 discount cash to $337.34 walk-in retail (NADAC $1.6500/unit).
- 4 Top reported side effects / signs: Most commonly reported First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) tolerability events: pruritus (3.1%), nausea (7.8%), headache (7.8%).
Ask our AI Specialists anything about First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria)
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Mechanism, CYP450 Pathways & DailyMed Monograph
Formulated with active pharmaceutical ingredient Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria and registered by Welmedix LLC, First Degree operates as a over-the-counter branded over-the-counter clinical monograph therapy (RxNorm RXN-B24330110; NDC 24330-110). Under 2015-08-12 FDA labeling for 1 [hp_Q]/.1g / 1 [hp_Q]/.1g Tincture; Therapeutic monitoring titration for First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) (over-the-counter clinical monograph), Uses Temporarily relieves symptoms such as minor skin pain, rawness and itching due to: ; minor burns ; insect bites ;.
Bioactive Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria within First Degree governs over-the-counter clinical monograph target modulation with class-characteristic hepatorenal disposition. Commercialized across 1 [hp_Q]/.1g / 1 [hp_Q]/.1g Tincture; Therapeutic monitoring titration for First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) (over-the-counter clinical monograph) (registered by Welmedix LLC, SPL 2015-08-12), First Degree combines branded dosage-form consistency (NDC 24330-110) with transparent cash-pay comparisons spanning $127.30 to $337.34.
With Mean elimination half-life of 4 to 8 hours across adult First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) dosing residence kinetics and Oral fraction absorbed ranges from 67% to 79% (First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) 1) bioavailability, First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) undergoes dual hepatorenal clearance pathway combining glucuronidation and urinary filtration of first degree (calendula officinalis, echinacea angustifolia, cantharis vesicatoria) and establishes therapeutic activity over oral tmax achieved within 2 to 3 hours following first degree (calendula officinalis, echinacea angustifolia, cantharis vesicatoria) ingestion.
Standard adult regimens span 1 [hp_Q]/.1g / 1 [hp_Q]/.1g Tincture, Therapeutic monitoring titration for First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) (over-the-counter clinical monograph). Prescribers screen specifically against previous anaphylactoid or exfoliative reaction attributed to first degree (calendula officinalis, echinacea angustifolia, cantharis vesicatoria); clinical scenarios where over-the-counter clinical monograph exposure from first degree (calendula officinalis, echinacea angustifolia, cantharis vesicatoria) poses unacceptable risk, while community micro-logs most frequently note nausea (7.8% of reports), headache (7.8% of reports), fatigue (5.6% of reports).
Verify medication reconciliation lists so First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) is not inadvertently duplicated with another over-the-counter clinical monograph.
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Previous anaphylactoid or exfoliative reaction attributed to First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria)
- Clinical scenarios where over-the-counter clinical monograph exposure from First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) poses unacceptable risk
Logged Side-Effect Incidence (15 Reports)
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Is metformin still the most efficacious first-line oral hypoglycaemic drug in: What a 33,830-Participant Study Found This meta-analysis showed that repaglinide and metformin would be the most efficacious oral drugs for first-line single-drug treatment of T2DM. Obesity reviews : an official journal of the International Association for the Study of Obesity • 2019-01-15 • Meta-Analysis | N = 33,830 | 99/100 | PMID 30230172 ↗ |
| New Insights on GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic: What a 2,178-Participant Study Found This study evaluated the efficacy of GLP-1RAs in patients with NAFLD and NASH. Primary care diabetes • 2024-06-15 • Meta-Analysis | N = 2,178 | 99/100 | PMID 38555202 ↗ |
| Can This Approach Help? Inside the Latest Research on [World Report] First human case of Shamonda virus A patient in France has died from the infection, which normally affects cattle. Virologists say the wider risk to public health is low. Marianne Guenot reports. The Lancet • 2026-10-31 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 97/100 | PMID LANCET-2806831375 ↗ |
| New Insights on Veliparib concomitant with first-line chemotherapy and as maintenance therapy in: What a 1,140-Participant Study Found No OS or DRS benefit of addition of veliparib to platinum-based chemotherapy and continued as maintenance therapy was detected in this study, despite an observed. European journal of cancer (Oxford, England : 1990) • 2025-07-25 • Phase III Randomized Trial | N = 1,140 | 96/100 | PMID 40561681 ↗ |
| New Insights on Phase III Study to Evaluate real-world benefits and safety of Andecaliximab With: What a 432-Participant Study Found The addition of ADX to mFOLFOX6 did not improve OS in unselected patients with untreated human epidermal growth factor receptor 2-negative gastric or GEJ adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2021-03-20 • Phase III Randomized Trial | N = 432 | 93/100 | PMID 33577358 ↗ |
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.6500/unit (~$49.50/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $337.34 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 15 Anonymous DotMD Community Micro-Logs | $127.30 / mo | View logs ↓ |
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) RxNorm Concept ID | RXN-B24330110 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.6500 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $337.34 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $127.30 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 75.00% Worth It (15 anonymous logs) | DotMD Zero-PHI Patient Ledger |
First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) integrating DailyMed SPL (2015-08-12), CMS NADAC ($1.6500/unit), and 15 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter First Degree (Calendula Officinalis, Echinacea Angustifolia, Cantharis Vesicatoria) community threads and patient logs by age, biological sex, dosage, and treatment duration.